Antibody targeting of glioblastoma shows promise in preclinical tests, say Lombardi researchers
Friday, July 31, 2009 - 13:07
in Health & Medicine
Washington, DC -- Cancer researchers at Georgetown University's Lombardi Comprehensive Cancer Center have successfully tested a small, engineered antibody they say shuts down growth of human glioblastoma tumors in cell and animal studies.